BusinessNetworkNewsWire Announces Publication on Exciting Treatment Advancements Through Gene TherapyBy Nasdaq OMXMar 1, 2018, 1:31 PM UTC
BusinessPreveCeutical Announces Appointment of Dr. Maher Khaled as Director of International OperationsBy Nasdaq OMXFeb 26, 2018, 2:30 PM UTC
BusinessMicrobubbles/Ultrasound Contrast Agents Market Worth 1,584.5 Million USD by 2024, Says Meticulous Research™By Nasdaq OMXFeb 20, 2018, 2:14 PM UTC
BusinessThe Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor DayBy Nasdaq OMXFeb 14, 2018, 3:35 PM UTC
BusinessAmarantus Subsidiary Cutanogen Corporation Announces Patent Issuance in Hong Kong Covering ESS, Pigmented ESS and Gene Therapy-Modified ESSBy Nasdaq OMXJan 4, 2018, 2:45 PM UTC
BusinessVoyager Therapeutics Highlights Lead Program VY-AADC for Advanced Parkinson’s Disease, AAV Novel Capsid and Delivery Optimization Efforts, and Pipeline Programs at its R&D DayBy Nasdaq OMXNov 16, 2017, 9:45 PM UTC
BusinessUltragenyx Announces Completion of Patient Dosing in First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) DeficiencyBy Nasdaq OMXNov 16, 2017, 1:30 PM UTC
BusinessAbeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIABy Nasdaq OMXNov 9, 2017, 1:45 PM UTC
